On August 30th, Injective faces a market downturn with its INJ token plummeting by 16%, diminishing hopes for short-term recovery. Despite this, on-chain developments continue, reinforcing Injective's community presence. Key announcements include the release of the web-based Remix Web IDE, simplifying smart contract development for developers. The IDE offers seamless access via the web, requiring no software installations.
Shayan, Developer Relations Manager at Injective Labs, highlights that the new IDE eliminates the need for software downloads, easing developers' frustrations. The platform aims to attract both new and experienced developers, marking a new era for Injective.
Additionally, Injective's collaboration with Helios on the 'Collabathon' aims to tackle cross-chain identity verification, enhancing interoperability and user experience. Scheduled for September 2nd, the event will feature expert developers from both entities, focusing on innovative Web3 finance solutions.
In terms of market trajectory, INJ revisits a crucial price level at $18.02, indicating potential for a rally if market conditions turn bullish. However, traders and investors are urged to exercise caution due to overall market volatility and sentiment. Long-term recovery targets are set at $23.37, contingent on broader market trends.
![Can Injective [INJ] reclaim the $35 level, trigger a rally?](https://loutre.blockchair.io/w4/storage/news/2d065a81e30cf52ab74493b9ec97beaa.png){kind=small}
